ARCHIVES

NCI, FDA Make Progress On Some Issues, Bu Differences Remain On Endpoints

This article is from The Cancer Letter archive.

Vol. 15 No. 43 | November 10, 1989

Download PDF Visit The Full Archive

Related Articles

CMS To Begin National Coverage Analysis Of Provenge

July 2, 2010

Existing HER2 Drugs May Help More In Breast Cancer Treatment

January 25, 2013

House Expected To Eliminate Earmarks, give NCI $2 Billion For FY94, A $40 Million Increase

June 18, 1993

FDA Officials Lists ‘Lessons’ Learned Working With AIDS Patient Organizations

August 14, 1992

Letter From Congress Prompts NCI To Pull Abortion Fact Sheet From Web

July 12, 2002

Sandra Swain Is Acting Chief Of NCI’s Medicine Branch.

July 21, 2000